Preoperative angiotensin-converting enzyme inhibitor use is not associated with increased postoperative pain and opioid use

Clinical Journal of Pain

Volumn 29, Issue 12, 2013, Pages 1050-1056

  Turan, Alparslan ^a   Atim, Abdulkadir ^a,b   Dalton, Jarrod E ^a   Keeyapaj, Worasak ^c   Chu, Weihan ^d   Bernstein, Ethan ^e   Fu, Alexander ^d   Jae Ho, Lee ^a   Saager, Leif ^a   Sessler, Daniel I ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Quantitative Health Sciences and Outcomes Research   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e UNIVERSITY OF ROCHESTER   (United States)

Author keywords

angiotensin converting enzyme inhibitors; postoperative; postoperative pain

Indexed keywords

ACETAMINOPHEN PLUS HYDROCODONE; ACETAMINOPHEN PLUS PROPOXYPHENE; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DEXTROPROPOXYPHENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FENTANYL; FOSINOPRIL; HYDROCODONE; HYDROMORPHONE; LISINOPRIL; MORPHINE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PETHIDINE; QUINAPRIL; RAMIPRIL; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; COLORECTAL SURGERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; HYPOTHESIS; HYSTERECTOMY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPENSITY SCORE; PROSTATECTOMY; SAMPLE SIZE; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ADULT; AGED; ANALGESICS, OPIOID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84887679804     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318287a258     Document Type: Article

References (33)

1. Dahl JB, Moniniche S. Pre-Emptive analgesia. Br Med Bull. 2004;71:13-27.
2. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: Physiological pathways and pharmacological modalities. Can J Anaesth. 2001;48:1000-1010.
3. Ji RR, Kohno T, Moore KA, et al. Central sensitization and LTP: Do pain and memory share similar mechanisms. Trends Neurosci. 2003;26:696-705.
4. Bhave G, Gereau RW. Posttranslational mechanisms of peripheral sensitization. J Neurobiol. 2004;61:88-106.
5. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: Risk factors and prevention. Lancet. 2006;367:1618-1625.
6. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1betamediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471-475.
7. Woolf CJ. Pain: Moving from symptom control toward mechanism-Specific pharmacologic management. Ann Intern Med. 2004;140:441-451.
8. IMS Health. Top therapeutic classes by U.S. dispensed prescriptions. April 6, 2010. Available at: Http://www.imshealth.com/deployedfiles/imshealth/ Global/Content/StaticFile/Top-Line-Data/Top%20Therapy%20Classes%20by%20U.S.RXs. pdf. Accessed November 15, 2010.
9. Unger T, Azizi M, Belz GG. Blocking the tissue reninangiotensin system: The future cornerstone of therapy. J Hum Hypertens. 2000;14(suppl 2):S23-S31.
10. Gales BJ, Bailey EK, Reed AN, et al. Angiotensin-Converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Ann Pharmacother. 2010;44:360-366.
11. Grafe M, Bossaller C, Graf K, et al. Effect of angiotensinconverting- Enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol. 1993;264:1493-1497.
12. Erdos EG, Deddish PA, Marcic BM. Potentiation of bradykinin actions by ACE inhibitors. Trends Endocrinol Metab. 1999;10:223-229.
13. Irvine RJ, White JM, Head RJ. The renin angiotensin system and nociception in spontaneously hypertensive rats. Life Sci. 1995;56:1073-1078.
14. Ercan S, Ilhan M, Turker KR. Alterations by captopril of pain reactions due to thermal stimulation of the mouse foot: Interactions with morphine, naloxone and aprotinin. Eur J Pharmacol. 1980;63:167-177.
15. de Mos M, Huygen FJ, Stricker BH, et al. The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-Inflammatory pathogenesis of CRPS. Pain. 2009;142:218-224.
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates Inc.; 1988.
17. Kaneko S, Mori A, Tamura S, et al. Intracerebroventricular administration of angiotensin II attenuates morphine-Induced analgesia in mice. Neuropharmacology. 1985;24:1131-1134.
18. Guasti L, Grimoldi P, Diolisi A, et al. Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension. 1998;31:1146-1150.
19. Brown DA, Passmore GM. Some new insights into the molecular mechanisms of pain perception. J Clin Invest. 2010;120:1380-1383.
20. Boix F, Roe C, Rosenborg L, et al. Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain. J Appl Physiol. 2005;98:534-540.
21. Li D-P, Pan H-L. Angiotensin II attenuates synaptic GABA release and excites paraventricular-Rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther. 2005;313:1035-1045.
22. Xing J, Kong J, Lu J, et al. Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway. Neurosci Lett. 2012;522:156-161.
23. Pelegrini-Da-Silva A, Rosa E, Guethe LM, et al. Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter. Neuroscience. 2009;164:1263-1273.
24. Imboden H, Patil J, Nussberger J, et al. Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia. Regul Pept. 2009;154:23-31.
25. Charles JA, Jotkowitz S, Byrd LH. Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache. 2006;46:503-507.
26. Schrader H, Stovner LJ, Helde G, et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): Randomized, placebo controlled, crossover study. Br Med J. 2001;322:19-22.
27. Gautam CS, Bhanwra S, Goel NK. Effect of captopril on pain perception in rats. Indian J Pharmacol. 2003;35:59-60.
28. Kalra J, Chaturvedi A, Kalra S, et al. Modulation of pain perception by ramipril and losartan in human volunteers. Indian J Physiol Pharmacol. 2008;52:91-96.
29. Ghione S. Hypertension-Associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension. 1996;28:494-504.
30. Guasti L, Zanotta D, Diolisi A, et al. Changes in pain perception during treatment with angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade. J Hypertens. 2002;20:485-491.
31. Rosa C, Ghione S. Effect of ketanserin on pain perception in arterial hypertension. Cardiovasc Drug Ther. 1990;4: 131-133.
32. Guasti L, Grimoldi P, Diolisi A, et al. Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension. 1998;31:1146-1150.
33. Irvine RJ, White JM. The effects of central and peripheral angiotensin on hypertension and nociception in rats. Pharmacol Biochem Behav. 1997;57:37-41.